The pta balloon catheter market has seen considerable growth due to a variety of factors.
• In recent times, the PTA balloon catheter market has seen rapid growth. Projected to expand from $2.33 billion in 2024 to $2.58 billion in 2025 with a compound annual growth rate (CAGR) of 10.4%, this expansion during the historic period may be due to factors like patient inclination towards non-invasive treatments, regulatory accreditations and standards, development in healthcare infrastructure, preferences and specializations of physicians, and an increase in occurrences of diabetes and obesity.
The pta balloon catheter market is expected to maintain its strong growth trajectory in upcoming years.
• In the forthcoming years, the market size for the PTA balloon catheter is predicted to experience substantial growth, reaching a valuation of $3.91 billion in 2029 with a compound annual growth rate (CAGR) of 11.0%.
The upsurge during the forecast period is largely due to burgeoning cases of cardiovascular disease, the dynamics of an aging population, emphasis on minimally invasive procedures, a rise in the rates of obesity and diabetes, and expansion of healthcare facilities. Key trends during this period are projected to be heightened training and education, a shift toward value-based healthcare, emphasis on safety and biocompatibility, integration of robotics and navigation systems, and personalized treatment options for patients.
The emerging pervasiveness of cardiovascular diseases is anticipated to stimulate the expansion of the PTA balloon catheter market. Cardiovascular diseases entail conditions that impact the heart or blood vessels. The escalation in these conditions necessitates sophisticated diagnostics and interventions, such as PTA balloon catheters, fostering increased market demand. For example, in May 2023, a report by The Indiana Department of Health (IDOH), a US-based website, suggested that out of approximately 250,000 central line-associated bloodstream infections (CLABSIs) that occur yearly in U.S. hospitals, around 80,000 are in intensive care units (ICUs). Hence, the enlarging pervasiveness of cardiovascular disorders is fuelling the expansion of the PTA balloon catheter market.
The PTA balloon catheter market covered in this report is segmented –
1) By Type: Polyurethane, Nylon
2) By Application: Coronary Artery Disease, Peripheral Vascular Disease
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Polyurethane: Non-compliant Balloons, Compliant Balloons
2) By Nylon: Non-compliant Balloons, Compliant Balloons
Prominent businesses in the PTA balloon catheter market are concentrating on pioneering products such as infusion systems to augment patient results and amplify procedural productivity. These infusion systems, which are essentially medical instruments designed to provide medications, nutrients or fluids intravenously to patients, permit careful control over dosage and flow rate, thus enhancing both treatment effectiveness and patient safety. For example, Terumo Corporation, a Japanese medical device firm, unveiled Terumo Medical Care Solutions (TMCS) in April 2022. In Terumo's endeavour to positively impact society through healthcare, TMCS represents a crucial leap forward. It aims to tackle current healthcare challenges while improving patient experiences by focusing on generating quality time for healthcare providers and patients alike. This initiative not only epitomizes Terumo's hundred-year history of medical technology but also strategically aligns it for future expansion in an increasingly intricate healthcare landscape.
Major companies operating in the PTA balloon catheter market include:
• Abbott Laboratories
• Medtronic PLC
• Boston Scientific Corporation
• Lepu Medical
• B. Braun Corporation
• Terumo
• Nipro Medical
• Teleflex
• Cook Medical
• Biotronik
• Merit Medical
• Microport Scientific
• Cardiovascular Systems
• Well Lead Medical
• Cardionovum
• Surmodics
• JOTEC
• Creagh Medical
• Natec Medical
• TriReme Medical
• Andratec
• Acotec Scientific
• Kaneka Corporation
North America was the largest region in the PTA balloon catheter market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the PTA balloon catheter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.